Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Cyr, CA

Andre M. Cyr, Belleville CA

Patent application numberDescriptionPublished
20110090796ADAPTIVELY MAINTAINING QUALITY OF SERVICE (QoS) IN DISTRIBUTED PBX NETWORKS - An adaptation mechanism monitors, maintains and controls quality of voice-grade for communications among end-systems in a distributed PBX topology, thereby providing an enhanced Quality of Service (QoS) for the network.04-21-2011

Benoit Cyr, St. Augustin De Desmaures CA

Patent application numberDescriptionPublished
20090004302Methods and Therapeutic Compositions Comprising Plant Extracts for the Treatment of Cancer - A method of treating cancer by targeting two proteases, MMP-9 and cathepsin B is provided. Therapeutic compositions comprising one or more plant extracts that inhibit MMP-9 and/or cathepsin B, which are capable of inhibiting neoplastic and/or endothelial cell migration, tumour growth, tumour-induced angiogenesis and/or metastasis are also provided. The therapeutic compositions of the invention can be used in the treatment of cancer, and, methods of inhibiting tumour growth, tumour metastasis, and/or tumour-induced angiogenesis using the therapeutic compositions alone or in combination with an anti-cancer agent are, therefore, also provided.01-01-2009
20090068291Plant extracts and compositions comprising extracellular protease inhibitors - The present invention provides a plant derived extract comprising inhibitory activity against one or more extracellular proteases which degrade human tissue matrix. Moreover, the amount of inhibitory activity in an extract can be increased by stressing the plant prior to forming an extract. These extracts are each prepared by a standard process and demonstrate the ability to inhibit one or more extracellular proteases which degrade human tissue matrix. Libraries of extracts can be prepared from stressed and non-stressed plants, wherein each of the extracts demonstrate inhibitory activity against one or more extracellular protease inhibitors. Alternatively, semi-purified and purified inhibitory compounds can be isolated from the extracts following standard procedures. In one aspect, these extracts with inhibitory activity can be used during protein purification to minimize the degradation due to extracellular proteases.03-12-2009
20090263516Plant Extract Composition and Their Use to Modulate Cellular Activity - Extracts from plant material, or semi-purified/purified molecules or compounds prepared from the extracts that demonstrate the ability to modulate one or more cellular activities are provided. The extracts are capable of slowing down, inhibiting or preventing cell migration, for example, the migration of endothelial cells or neoplastic cells and thus, the use of the extracts to slow down, inhibit or prevent abnormal cell migration in an animal is also provided. Methods of selecting and preparing the plant extracts and methods of screening the extracts to determine their ability to modulate one or more cellular activity are described. The purification or semi-purification of one or more molecules from the described extracts is also contemplated as well as the use of these molecules, alone or in combination with an extract, to slow down, inhibit or prevent abnormal cell migration in an animal.10-22-2009
20110177014EXTRACTS FROM PLANTS OF THE TSUGA GENUS AND USES THEREOF IN THE TREATMENT OF INFLAMMATION, IRRITATION AND/OR INFECTION - Extracts derived from plants of the 07-21-2011
20110217753INHIBITORS OF EXTRACELLULAR PROTEASES - Provided is a plant derived extract including inhibitory activity against one or more extracellular proteases which degrade human tissue matrix. Moreover, the amount of inhibitory activity in an extract can be increased by stressing the plant prior to forming an extract. These extracts are each prepared by a process and demonstrate the ability to inhibit one or more extracellular proteases which degrade human tissue matrix. Libraries of extracts can be prepared from stressed and non-stressed plants, where each of the extracts demonstrate inhibitory activity against on or more extracellular protease inhibitors. Alternatively, semi-purified and purified inhibitory compounds can be isolated from the extracts. In one aspect, these extracts with inhibitory activity can be used during protein purification to minimize degradation due to extracellular proteases.09-08-2011

Benoit Cyr, Quebec CA

Patent application numberDescriptionPublished
20100323041METHODS AND THERAPEUTIC COMPOSITIONS COMPRISING PLANT EXTRACTS FOR THE TREATMENT OF CANCER - A method of treating cancer by targeting two proteases, MMP-9 and cathepsin B is provided. Therapeutic compositions comprising one or more plant extracts that inhibit MMP-9 and/or cathepsin B, which are capable of inhibiting neoplastic and/or endothelial cell migration, tumor growth, tumor-induced angiogenesis and/or metastasis are also provided. The therapeutic compositions of the invention can be used in the treatment of cancer, and methods of inhibiting tumor growth, tumor metastasis, and/or tumor-induced angiogenesis using the therapeutic compositions alone or in combination with an anti-cancer agent are, therefore, also provided.12-23-2010

Cameron Edward Cyr, Whitby CA

Patent application numberDescriptionPublished
20090270179COMPUTERIZED SYSTEM AND METHOD OF ORGANIZING BILLIARDS COMPETITIONS - The present invention is a computerized system and method of organizing participants in billiards competitions. Specifically, the computerized system and method does the scheduling, tracking and scoring of the participants in billiards competitions. The computerized system utilizes client server technology over a computerized network such as the Internet, with a relational database and a database management system. The method utilizes a scheduling system for scheduling participants in billiards competitions, a handicap system for allowing participants of all skill levels to competitively participate with each other and a point system for measuring participant performance in billiards competitions. The method of utilizing the scheduling system, the handicap system and the point system is integrated into the computerized system.10-29-2009

Claude Cyr, Longueuil CA

Patent application numberDescriptionPublished
20100040993APPARATUS AND METHOD FOR DETECTING DENTAL PATHOLOGIES - A diagnostic tool for detection of dental pathology is provided that functions as a self-contained, handheld unit. The tool includes a light probe and a housing within which are located an optical source, an optical detector, an analysis processor and a power source. The components within the housing are integrated on a support which is removable from the housing. The housing is in multiple pieces which may be connected together during operation, and disconnected to allow removal of the support. This allows for sterilization of the housing and light probe without the electrical components of the device.02-18-2010

Jean-Marc Cyr, Candiac CA

Patent application numberDescriptionPublished
20080309262Multiple Phase Electric Motor and Drive - A multiple phase electric motor provided with multiple inverter power circuits is described herein. The capacity of the capacitor bank required for multiple phase motors operating from a DC power source is therefore decreased. This is done by forming groups of phases that are powered by a separate inverter power circuit. The inverter power circuits are connected to the same DC power source including a bank of capacitors and are so controlled as to be phase offset from one another to allow the use of a smaller capacity capacitor bank.12-18-2008
20090286652System and Method for Starting a Combustion Engine of a Hybrid Vehicle - A system and method for starting an ICE of a hybrid vehicle, the hybrid vehicle having a generator with a rotor rotating at an angular speed and a clutch provided between the ICE and the rotor. The method includes steps of disengaging the clutch so that the rotor and the ICE can operate independently; increasing the angular speed; upon the angular speed reaching a predetermined speed, engaging the clutch; allowing the ICE to crank; and starting the ICE.11-19-2009

Patent applications by Jean-Marc Cyr, Candiac CA

Lawrence Gerald Cyr, Red Deer CA

Patent application numberDescriptionPublished
20110174501CABLE BYPASS AND METHOD FOR CONTROLLED ENTRY OF A TUBING STRING AND A CABLE ADJACENT THERETO - A system and methodology for controlled entry of a tubing string, and cable adjacent thereto, into a wellbore. A stationary housing is fit to a wellhead and has a bore in communication with the wellbore. The cable can be laterally displaced from the bore into a cable access formed into the housing's side wall for fitting a sealing assembly to the bore and engages a sealing surface therein. The sealing assembly seals tubulars passing therethrough. The cable access interrupts the sealing surface. A cable bypass sub is fit to the cable access and permits the cable to extend sealingly from above the sealing surface to the wellbore wherein the cable bypasses the sealing assembly and sealing surface. A seal reconstitutes the interrupted portion of the sealing surface at the cable access.07-21-2011

Nicolas Cyr, Greenfield Park CA

Patent application numberDescriptionPublished
20110219608ELECTROCHEMICAL BATTERY AND METHOD FOR MAKING SAME - A method for making a battery is disclosed which comprises providing a plurality of Electrochemical Cell (EC) bundles; providing a current collecting terminal having first and second ends; electrically connecting the projections of the sheet like electrodes extending from one end a first EC bundle together via the first end of the current collecting terminal; electrically connecting the projections of the sheet like electrodes extending from one end of a second EC bundle together via the second end of the current collecting terminal such that the first and second EC bundles are mechanically and electrically connected together and form a string of at least two EC bundles; and folding the string of at least two EC bundles by bending the current collecting terminal connecting the at least two EC bundles together such that the first and second EC bundles are positioned in a side by side relationship.09-15-2011

Normand Cyr, Quebec CA

Patent application numberDescriptionPublished
20090244522Polarization Optical Time Domain Reflectometer and Method of Determining PMD - In a method of measuring cumulative polarization mode dispersion (PMD) along the length of a fiber-under-test (FUT), a polarization-sensitive optical time domain reflectometer (POTDR) is used to inject into the FUT plural series of light pulses arranged in several groups. Each group comprises at least two series of light pulses having different but closely-spaced wavelengths and the same state of polarization (SOP). At least two, and preferably a large number of such groups, are injected and corresponding OTDR traces obtained for each series of light pulses by averaging the impulse-response signals of the several series of light pulses in the group. The process is repeated for a large number of groups having different wavelengths and/or SOPs. The PMD then is obtained by normalizing the OTDR traces of all of the groups, then computing the difference between each normalized OTDR trace in one group and the corresponding normalized OTDR trace in another group, followed by the mean-square value of the differences. Finally, the PMD is computed as a predetermined function of the mean-square difference. The function may, for example, be a differential formula, an arcsine formula, and so on.10-01-2009
20100073667Method and Apparatus for Determining Differential Group Delay and Polarization Mode Dispersion - A method and apparatus for measuring at least one polarization-related characteristic of an optical path (FUT) uses an optical source means connected to the FUT at or adjacent a proximal end of the FUT and an analyzing-and-detection unit connected to the FUT at or adjacent its proximal or distal end. The optical source means injects into the FUT at least partially polarized light having a controlled state of polarization (I-SOP). The analyzer-and-detection unit extracts corresponding light from the FUT, analyzes and detects the extracted light corresponding to at least one transmission axis (A-SOP), and processes the corresponding electrical signal to obtain transmitted coherent optical power at each wavelength of light in each of at least two groups of wavelengths, wherein the lowermost (λ03-25-2010
20110091206IN-BAND OPTICAL NOISE MEASUREMENT USING DIFFERENTIAL POLARIZATION RESPONSE - A method comprises: acquiring, for a number nSOP of varied State-Of-Polarization analysis conditions of the input optical signal, nSOP polarization-analyzed optical spectrum traces; mathematically discriminating said signal contribution from said noise contribution within said optical signal bandwidth using said polarization-analyzed optical spectrum traces, said mathematically discriminating comprising: obtaining a differential polarization response that is related to the optical spectrum of said signal contribution by a constant of proportionality; estimating the constant of proportionality of a differential polarization response to the optical spectrum of said signal contribution; estimating the optical spectrum of said noise contribution from said input optical signal, within said optical signal bandwidth using said constant of proportionality and said differential polarization response; and determining said in-band noise parameter on said input optical signal from the mathematically discriminated noise contribution.04-21-2011

Patent applications by Normand Cyr, Quebec CA

Raymond Cyr, Laval CA

Sonya L. Cyr, Laval CA

Patent application numberDescriptionPublished
20100203071CHIMERIC ANTIGENS - Chimeric respiratory syncytial virus (RSV) polypeptide antigens are provided. The disclosed polypeptides include in an N-terminal to C-terminal direction: a first F protein polypeptide domain; a G protein polypeptide domain; and a second F protein polypeptide domain. The disclosure also provides nucleic acids that encode, and pharmaceutical compositions that contain, the chimeric RSV polypeptides, as well as methods for their production and use.08-12-2010